HCA240719C335000
- 0.18
- 0.000.00%
HCA Healthcare Newsroom
Express News | HCA Healthcare Inc : Raymond James Raises Target Price to $375 From $330
Cantor Fitzgerald Reiterates Overweight on HCA Healthcare, Maintains $335 Price Target
Raymond James Adjusts HCA Healthcare's PT to $375 From $330, Maintains Outperform Rating
HCA Healthcare Is Maintained at Outperform by Leerink Partners
Earnings Call: HCA Healthcare Reports Robust Q2 Results, Updates Guidance
HCA Healthcare Price Target Raised to $390.00/Share From $375.00 by Truist Securities
A Quick Look at Today's Ratings for HCA Healthcare(HCA.US), With a Forecast Between $340 to $397
Oppenheimer Maintains Outperform on HCA Healthcare, Raises Price Target to $390
HCA Healthcare Analyst Ratings
Express News | HCA Healthcare Inc : BofA Global Research Raises Price Objective to $410 From $397
Express News | HCA Healthcare Inc : Truist Securities Raises Target Price to $390 From $375
Express News | Asensus Surgical Announced That The Rocky Mountain Hospital For Children In Denver, Colorado, Part Of HCA Healthcare's HealthONE Network, Has Entered Into An Agreement To Utilize A Senhance Surgical System
RBC Capital Reaffirms Their Buy Rating on HCA Healthcare (HCA)
Express News | HCA Healthcare, Inc. : Barclays Raises Target Price to $396 From $376
Truist Adjusts Price Target on HCA Healthcare to $390 From $375, Maintains Buy Rating
HCA Healthcare: Strong Q2 Financials and Optimistic Outlook Justify Buy Rating
Analysts Have Conflicting Sentiments on These Healthcare Companies: Biohaven Ltd. (BHVN), HCA Healthcare (HCA) and Kiniksa Pharmaceuticals (KNSA)
HCA Healthcare's Net Income Increases to $1.46bn in Q2 2024
Buy Rating Affirmed for HCA Healthcare Amid Robust Growth and Positive Outlook
Analysts' Opinions Are Mixed on These Healthcare Stocks: HCA Healthcare (HCA), Oric Pharmaceuticals (ORIC) and GoodRx Holdings (GDRX)